Regulation of Preantral Follicles

腔前卵泡的调节

基本信息

  • 批准号:
    7436183
  • 负责人:
  • 金额:
    $ 24.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Folliculogenesis (the growth of an ovarian follicle from the primordial stage to ovulation) is a more prolonged event than is widely appreciated, requiring more than 220 days in humans. The vast majority of this time is spent as a preantral follicle, yet very little is known about the regulation of the growth and development of these follicles. Members of the TGFbeta growth factor family induce distinct quantifiable effects in preantral follicles in culture. Deletion of the TGFbeta family signaling molecule, Smad3 results in decreased number of preantral follicles and infertility in the mouse. Follicles deficient in Smad3 do not respond normally to FSH treatment. The overall goal of this research is to determine the regulators of early follicle development. This proposal will determine the role of Smad3 in early follicle development by achieving the following aims. Specific Aim 1- Is Smad3 essential for optimal preantral follicle growth in response to FSH? This aim will determine quantitative and qualitative changes in FSH-stimulated preantral follicle growth and development in the ovary of the Smad3 deficient mouse compared to wild-type. Specific Aim 2- Does Smad3 impact FSH stimulation of granulosa cell function? This aim will use granulosa cell culture techniques to determine the integrity of the FSH signaling pathway in the absence of Smad3 and the effects of direct modulation of Smad2 and Smad3 function on FSH signaling. Specific Aim 3 - Does manipulation of Smad3 function modulate FSH-stimulated early follicle growth? In this aim we will restore Smad3 function to Smad3 deficient preantral follicles to determine if FSH responsiveness is restored. We will also directly manipulate Smad2 and Smad3 function to determine the independent and combined roles of Smad2 and Smad3 in regulating preantral follicle development. The elucidation of the mechanisms of regulation of early follicle growth, differentiation and apoptosis has profound implications for developing new non-hormonal contraceptives and treatments for ovarian causes of infertility. Additionally, the ability to manipulate the rate of loss of follicles from the finite pool of ovarian follicles could impact the timing of menopause and ovarian aging. Increased knowledge of the determinants of healthy early follicle development will also benefit the emerging field of ovarian cryopreservation and in vitro follicle development.
描述(由申请人提供):卵泡发生(卵巢卵泡从原始阶段到排卵的生长)是一个比普遍认为的更长时间的事件,在人类中需要超过220天。这段时间的绝大部分是作为腔前卵泡度过的,然而对这些卵泡的生长和发育的调节知之甚少。tgf - β生长因子家族的成员在培养的腔前卵泡中诱导明显的可量化效应。TGFbeta家族信号分子Smad3的缺失导致小鼠腔前卵泡数量减少和不孕。缺乏Smad3的卵泡对FSH治疗反应不正常。本研究的总体目标是确定早期卵泡发育的调节因子。该建议将通过实现以下目标来确定Smad3在早期卵泡发育中的作用。特异性目标1- Smad3对促卵泡刺激素反应的最佳腔前卵泡生长至关重要吗?该目的将确定与野生型相比,fsh刺激Smad3缺陷小鼠卵巢中卵泡前生长和发育的定量和定性变化。特异性目标2- Smad3是否影响FSH刺激颗粒细胞功能?该目标将使用颗粒细胞培养技术来确定缺乏Smad3时FSH信号通路的完整性,以及Smad2和Smad3功能的直接调节对FSH信号通路的影响。特异性目标3 -操纵Smad3功能是否调节fsh刺激的早期卵泡生长?在这个目的中,我们将恢复Smad3缺陷的前腔卵泡的功能,以确定FSH反应性是否恢复。我们还将直接操纵Smad2和Smad3的功能,以确定Smad2和Smad3在调节腔前卵泡发育中的独立和联合作用。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regenerative medicine meets gynecology.
再生医学与妇科的结合。
Smad3 is required for normal follicular follicle-stimulating hormone responsiveness in the mouse.
  • DOI:
    10.1095/biolreprod.108.070086
  • 发表时间:
    2009-10
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Gong X;McGee EA
  • 通讯作者:
    McGee EA
An Extra Arm May Impair the Open Hand.
额外的手臂可能会损害张开的手。
  • DOI:
    10.1210/en.2015-1538
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    McGee,ElizabethA;Raj,RenjuS
  • 通讯作者:
    Raj,RenjuS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH A MCGEE其他文献

ELIZABETH A MCGEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH A MCGEE', 18)}}的其他基金

The Utility of Empiric Medical Treatment of Infertile Oligo-asthenospermic Men
经验性药物治疗对不育少弱精子症男性的效用
  • 批准号:
    8588703
  • 财政年份:
    2007
  • 资助金额:
    $ 24.92万
  • 项目类别:
Regulation of Preantral Follicles
腔前卵泡的调节
  • 批准号:
    7038283
  • 财政年份:
    2004
  • 资助金额:
    $ 24.92万
  • 项目类别:
Regulation of Preantral Follicles
腔前卵泡的调节
  • 批准号:
    7226969
  • 财政年份:
    2004
  • 资助金额:
    $ 24.92万
  • 项目类别:
Regulation of Preantral Follicles
腔前卵泡的调节
  • 批准号:
    6905612
  • 财政年份:
    2004
  • 资助金额:
    $ 24.92万
  • 项目类别:
Regulation of Preantral Follicles
腔前卵泡的调节
  • 批准号:
    7363484
  • 财政年份:
    2004
  • 资助金额:
    $ 24.92万
  • 项目类别:
Regulation of Preantral Follicles
腔前卵泡的调节
  • 批准号:
    6821811
  • 财政年份:
    2004
  • 资助金额:
    $ 24.92万
  • 项目类别:

相似海外基金

Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
  • 批准号:
    19K09482
  • 财政年份:
    2019
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
  • 批准号:
    2273599
  • 财政年份:
    2019
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
  • 批准号:
    18K14964
  • 财政年份:
    2018
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
  • 批准号:
    16K18873
  • 财政年份:
    2016
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
  • 批准号:
    9193681
  • 财政年份:
    2016
  • 资助金额:
    $ 24.92万
  • 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
  • 批准号:
    15K18939
  • 财政年份:
    2015
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
  • 批准号:
    26450450
  • 财政年份:
    2014
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
  • 批准号:
    26462183
  • 财政年份:
    2014
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
  • 批准号:
    26893253
  • 财政年份:
    2014
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
  • 批准号:
    24701021
  • 财政年份:
    2012
  • 资助金额:
    $ 24.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了